Healing, Relapse Rates and Prophylaxis of Reflux Esophagitis

References

• Castell D O. Medical therapv for reflux esophagitis: 1986 and bevond. Ann bit Med 1986; 104: 112–114
   Google Scholar
• Behar Brand J. D, Brown L. F, Castell C. D, Cohen O. S, Crossley R, Pope J. CE, II, Winans C S. Cimetidine in the treatment of symptomatic gastroesophageal reflux. A double blind controlled trial. Gastroenterology 1978; 74: 441–48
   PubMedGoogle Scholar
• Wesdorp Bartelsman E., Pape J. K, Dekker W, Tytgat G N. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978; 74: 821–824
   PubMedGoogle Scholar
• Sonnenberg Lepsien A., Beiges G. W, Weber K B, Wienbeck M, Siewert J R, Blum A L. Cimetidin-behandlung der Refluxosophagitis. Ergebnisse einer Doppeltblindstudie. Schweiz Med Wschr 1979; 109(16)613–615
   PubMedGoogle Scholar
• Lepsien G, Weiser H F, Blum A L, Siewert J R. Erste Behandluiigsergebnisse bei der erosiven Refluxösophagitis mit Cimetidin - eine Doppeltblindstudie. Schweiz Med Wschr 1978; 108(28)1094
   Google Scholar
• Brown P. Cimetidine in die treatment of reflux oesophagitis. Med J Aust 1979; 2(2)96–97
   PubMed Web of Science ®Google Scholar
• Fiasse R., Hanin C, Lepot A, Descamps C, Lamy F, Dive C. Controlled trial of cimetidine in reflux esophagitis. Dig Dis Sci 1980; 25: 750–758
   PubMed Web of Science ®Google Scholar
• Festen H, Driessen P. W, Lamers M. C, Van B., Tonge-Ren J H. Cimetidine in the treatment of severe ulcerative reflux oesophagitis; Results of an 8-week double-blind study and of subsequent long-term maintenance treatment. Neth J Med 1980; 23: 237–240
   PubMed Web of Science ®Google Scholar
• Greaney M G, Irvin T T. Cimetidine for the treatment of symptomatic gastro-oesophageal reflux. Brit J Clin Pract 1981; 35: 21–24
   PubMedGoogle Scholar
• Wesdorp I, Dekker C., Klinkenberg W., Knol E C. Treatment of reflux oesophagitis with ranitidine. Gut 1983; 24: 921–24
   PubMed Web of Science ®Google Scholar
• Gov J, Maynard A. J, Mc H., Naughton W M, O'Shea A. Ranitidine and placebo in die treatment of reflux oesophagitis. A double-blind randomized trial. Med J Aust 1983; 2(11)558–561
   PubMedGoogle Scholar
• Lehtola Niemela J., Martikainen S., Krekela J. I. Ranitidine. 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled. double-blind study. Seand J Gastroenterol 1986; 21: 175–180
   PubMedGoogle Scholar
• Sontag Robinson S., Mc M., Callum R, Barwiek W. K, Nardi W. R. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Arch Intern Med 1987; 147: 1485–9
   PubMedGoogle Scholar
• Evreux M. Sucralfate versus alginate antacid in die treatment of peptic esophagitis. Am J Med 1987; 83: 48–50
   PubMed Web of Science ®Google Scholar
• Simon B, Mueller P. Comparison of the effect of sucralfate and ranitidine in reflux esophagitis. Am J Med 1987; 83: 43–47
   PubMed Web of Science ®Google Scholar
• Hameeteman Boomgaard W. D, Dekker M. W., Schrijver M, Wesdorp I C, Tytgat G N. Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter study. J Clin Gastroenterol 1987; 9: 390–394
   PubMedGoogle Scholar
• Laitinen S, Stahlberg M, Kairaluoma M., Kiviniemi H, Paakkonen M, Lahtinen J, Poikolainen E, Aukee S. Sucralfate and alginate/antacid in reflux esophagitis. Scand J Gastroenterol 1985; 20: 229–232
   PubMed Web of Science ®Google Scholar
• Weiss Bruimer W. H, Biittner G R, Gabor M, Mie-Derer S, Mittelstaedt A, Olbennann M, Schwam-Berger K, Witzel L. Therapie der Refluxosophagitis mit Sucralfat. Deutsch Med Wschr 1983; 45: 1706–11
   Google Scholar
• Williams R M, Orlando R, Bozvmski C. EM, Readling R D, Castell D O, Roufael W M, Rick G G, et al. Multi-center trial of sucralfate suspension for tbe treatment of reflux esophagitis. Am J Med 1987; 83(suppl 3 B)61–66
   PubMedGoogle Scholar
• Carling L, Cronstedt Engqvist J. A, Kagevi I, Nv-strom Svedberg B. L-E, Torhallson E, et al. Sucralfate versus placebo in reflux esophagitis – a double blind multicentre studv. Scand J Gastroenterol 1988
   PubMedGoogle Scholar
• Tytgat G N. Medical therapy of reflux esophagitis. Diseases of the esophagus, J R Siewert, A H Holscher. Springer Verlag, Berlin 1987; 1137–1147
   Google Scholar
• Lepoutre L, Bollen Vandewalle J. N, Laukens Cabooter P., Vanderlinden M. I. Therapeutic effect of cisapride in reflux esophagitis: a double blind. placebo controlled study. Progress in the treatment of gastrointestinal motility disorders: the role of cisapride, A Johnson, G. G Lux. Excerpta medica, Amsterdam 1988; 63–65
   Google Scholar
• Galmiche J P, Brandstatter Evreux G., Hentschel M., Kerstan E. E, Kratochvil Reichel P., Schulze W. K, et al. Combined therapy with cisapride and cimetidine in severe reflux esophagitis; a double blind controlled trial. Gut 1988; 29: 67.5–681
   Google Scholar
• Wienbeck M., The ranprid study group. Therapeutic effect of cisapride added to ranitidine in patients with reflux esophagitis. Dig Dis Sci 1986; 31: 27S, abstract 97
   PubMed Web of Science ®Google Scholar
• Evreux Founiet M. J, Galmiche J, Soule P., Vitaux J., Zeitoun P. P. Endoscopic and clinical evaluation of cisapride and cimetidine in reflux esophagitis. Gastroenterology 1988; 94(5)A120, part 2
   Google Scholar
• Dent J, Hetzel D J, Reed W D, Narielvala F M, Mitchell B L, McCarthy J H. Healing of peptic esophagitis with omeprazole. Gastroenterology 1986; 90: 1392
   Web of Science ®Google Scholar
• Klinkenberg Knol E C, Jansen J M, Festen H P, Meuwissen S G, Earners C B. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1: 349–351
   PubMedGoogle Scholar
• Vantrappen G, Coenegrachts J L, Rutgeerts L, Schurmans P. Omeprazole (40 nig) is superior to ranitidine in the short term treatment of ulcerative reflux esophagitis. Gastroenterology 1987; 92: 1681
   Web of Science ®Google Scholar
• Havelund T, Laursen L S, Skoubo-Kristensen E, Andersen B N, Pedersen S A, Jensen K B, Fenger C, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Brit Med J 1988; 296: 89–92
   PubMed Web of Science ®Google Scholar
• Zeitoun P, Desjars N, Isal J P. Omeprazole versus ranitidine in erosive oesophagitis. Lancet 1987; 2: 621–22
   PubMedGoogle Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 652–632
   Google Scholar
• Hetzel D J, Dent J, Reed W, Mitchell B, Beveridgc B, Laurence B, Mackinnon M, et al. Healing of peptic esophagitis with omeprazole: A dose-response study. Gastroenterology 1987; 92: 1434
   Google Scholar
• Bright-Asare P, Behar J, Brand D L, Brown F C, Castell D O, Cohen S, Debas H, et al. Effects of long term maintenance cimetidine (CIM) tlierapy on gastroesophageal reflux disease (GERD). Gastroenterology 1982; 82: 1025
   Web of Science ®Google Scholar
• Koelz H R, Birchler R, Brelholz A, Bron B, Capitaine Y, Delmore G, Felir H F, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• McCallum R W, Sontag S J, Vlahcevic Z R, Robinson M G, On W C, Zimmennann T W, Behar J, et al. Ranitidine vs. placebo in long-term treatment of gastroesophagel reflux. Am J Gastroenterology 1985; 80: 864, No. 150
   Google Scholar
• Ottenjann R, Siewert J R, Heilman K, Ness A, Döpfer H. Treatment of reflux esophagitis: results of a multicenter study. Diseases of the esophagus, J R Siewert, A H Hölscher. Springer Verlag, Berlin 1987; 1125
   Google Scholar
• Lieberman D A. Medical therapy for chronic reflux esophagitis. Arch Intern Med 1987; 147: 1717–1720
   PubMedGoogle Scholar
• Kaul B, Petersen H, Erichsen H, Myrvold H E, Grette K, Halvorsen T, Fjosne U. Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine. Scand J Gastroenterol 1986; 21: 139–145
   PubMed Web of Science ®Google Scholar
• Castell D. Long-term tlierapy for chronic gastroesophageal reflux. Arch Intern Med 1987; 147: 1701–1702
   PubMedGoogle Scholar
• Behar J, Sheahan D G, Biancani P, Spiro H M, Storer E H. Medical and surgical management of reflux esophagitis. A 38-month report on a prospective clinical trial. N Engl J Med 1975; 293: 263–268
   PubMed Web of Science ®Google Scholar
• Johansson K FL, Tibbling L. Maintenance treatment with ranitidine compared with fundoplication in gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 779–788
   PubMed Web of Science ®Google Scholar
• Johnsson H, Joelson B, Gudmundsson K, Floren C H, Walther B. Effects of fundoplication on the antireflux mechanism. Br J Surg 1987; 74: 1111–1114
   PubMedGoogle Scholar
• Orlando R C. Esophageal epithelial resistance. Gastroesophageal reflux disease: pathogenesis, diagnosis, therapy, D O Castell, W C Wu, D J Ott. Futura Publishing Co, Mount Kisco, NY 1985; 55–79
   Google Scholar
• Hamilton B H, Tobey N A, Schreiner V J, Brocking-Ton J C, Orlando R C. In vivo bicarbonate (1IC0:3) secretion by mammalian esophagus. Dig Dis Week 1988, abstr. 229
   Google Scholar